Journal of Obstetric and Gynaecological Practices POGS

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  3 (2025)
Volume  2 (2024)
Volume  1 (2023)
Related articles

VOLUME 3 , ISSUE 1 ( January-June, 2025 ) > List of Articles

Original Article

The Characteristics of Pregnant Women with Cardiac Disease in Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar

Anak AGP Wiradnyana, I Made Darmayasa, Kade Y Saspriyana, Aldo A Lawu

Keywords : Cardiac disease, Characteristics, Morbidity, Mortality, Pregnancy

Citation Information : Wiradnyana AA, Darmayasa IM, Saspriyana KY, Lawu AA. The Characteristics of Pregnant Women with Cardiac Disease in Prof. Dr. I.G.N.G. Ngoerah Hospital, Denpasar. J Obstet Gynaecol 2025; 3 (1):8-21.

DOI: 10.5005/jogyp-11012-0048

License: CC BY-NC 4.0

Published Online: 12-02-2025

Copyright Statement:  Copyright © 2025; The Author(s).


Abstract

Introduction: Increased cardiac output, decreased systemic vascular resistance, and left ventricular hypertrophy are among the cardiovascular alterations brought on by pregnancy. Pregnancy-related heart problems can increase the risk of morbidity and death in both the mother and the newborn. The aim of this research is to characterizing the characteristics of pregnant women with heart disease patients in RSUP Prof. Dr. I.G.N.G. Ngoerah, Denpasar, Indonesia. Methods: This research is included in the type of retrospective descriptive research using medical record data at this hospital from 1 January 2020 to 31 December 2021 with a total sampling method. Inclusion criteria include all cardiac disease in pregnancy cases. Cases with incomplete data were excluded. Data were subsequently analyzed with SPSS 26th edition. Results: There were 46 cases of cardiac disease in pregnancy recorded and 4 cases were excluded. The prevalence in pregnancy was 2.68%. The characteristics of most of the cases were in 20–35 years old group (71.4%), high school graduates (69.0%), normal body mass index (38.1%), multigravida (64.3%), diagnosed at ≥37 gestational age (52.4%), booked case (85.7%), with known previous cardiac disease (54.8%), diagnosed with congenital heart disease (23.8%), WHO class IV (33.3%), underwent cesarean section (71.4%), birth weight <2,500 gram (52.4%), vigorous baby (71.4%), used IUD as postpartum contraception (45.2%), hospitalized in intensive ward after delivery (52.4%) and length of stay were 5–10 days (45.2%). There were 4 maternal mortality cases with case fatality rate (CFR) of 9.52% caused by respiratory failure, sepsis and cardiogenic shock. Discussion: There was a slight increase in prevalence and decrease of CFR of cardiac disease in pregnancy in our hospital compared to previous data in 2016–2017 which may cause by better referral system and patient care. Conclusion: In general, the characteristics of patients in our study were similar to previous studies in developing countries.

PDF Share
  1. Elfil AMH, Yassin K. Epidemiology of cardiac disease during pregnancy in Khartoum Hospital, Sudan. Journal of Women's Health Care 2015;4(2):1–4. DOI: 10.4172/2167-0420.1000227.
  2. Vaughan G, Dawson A, Peek MJ, et al. Standardizing clinical care measures of rheumatic heart disease in pregnancy: A qualitative synthesis. Birth 2019;46(4):560–573. DOI: 10.1111/BIRT.12435.
  3. Kawwass JF, Badell ML. Maternal and fetal risk associated with assisted reproductive technology. Obstet Gynecol 2018;132(3):763–772. DOI: 10.1097/aog.0000000000002786.
  4. Ersbøll AS, Damm P, Gustafsson F, et al. Peripartum cardiomyopathy: A systematic literature review. Acta Obstet Gynecol Scand 2016;95(11):1205–1219. DOI: 10.1111/aogs.13005
  5. Wiyati PS, Wibowo B. Luaran maternal dan perinatal pada hamil dengan penyakit jantung di RSUP Dr. Kariadi Semarang. Majalah Obstetri dan Ginekologi 2013;21(1):20–30. ISSN: 0854-0381.
  6. Nirmala C. Perbedaan antara Jenis dan Derajat Kelainan Jantung serta Jenis Persalinan terhadap Outcome Ibu dan Bayi pada Kehamilan dengan Penyakit Jantung. Obgynia 2019;2(1):42–51. DOI: 10.24198/obgynia.v2n1.87.
  7. Warsita IGN, Negara KS, Wiradnyana AAGP, et al. Karakteristik pasien hamil dengan penyakit jantung di RSUP Sanglah Denpasar. Med J 2019;50(3). DOI: 10.15562/medicina.v50i3.715.
  8. Adam K. Pregnancy in women with cardiovascular diseases. Methodist DeBakey Cardiovasc J 2017;13(4):209–215. DOI: 10.14797/mdcj-13-4-209.
  9. Ashrafi R, Curtis SL. Heart disease and pregnancy. Cardiol Ther 2017;6(2):157–173. DOI: 10.1007/s40119-017-0096-4.
  10. Kennedy BB, Baird SM. Acute myocardial infarction in pregnancy: An update. J Perinat Neonatal Nurs 2016;30(1):13–24. DOI: 10.1097/jpn.0000000000000145.
  11. Sumalatha B, Jyotsna M, Indrani G. Electrocardiographic Changes during Normal Pregnancy. Indian J Cardiovasc Dis Women WINCARS 2017;2(3):35–38. DOI: 10.1055/s-0037-1606853.
  12. Taranikanti M. Physiological changes in cardiovascular system during normal pregnancy: A review. Indian J Cardiovasc Dis Women WINCARS 2018;3(2/3):62–67. DOI: 10.1055/s-0038-1676666.
  13. Anupama H. Role of electrocardiogram and echocardiogram in pregnancy. Indian Journal of Cardiovascular Disease in Women WINCARS 2017;2(3):2–3. DOI: 10.1055/s-0037-1606849.
  14. Curettagek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. European Heart Journal 2018;39(34):3165–3241. DOI: 10.1093/eurheartj/ehy340.
  15. Conrad KP. Maternal vasodilation in pregnancy: The emerging role of relaxin. Am J Physiol-Regul Integr Comp Physiol 2011;301(2):R267–R275. DOI: 0.1152/ajpregu.00156.2011.
  16. Ablett J. Cardiac disease in pregnancy. Cardiac Disease in Pregnancy Guideline 2018;14:137–143. Greater Manchester and Eastern Cheshire (GMEC). (2022). Cardiac Disease in Pregnancy: FINAL V2. NHS England North West. Available from: https://www.england.nhs.uk/north-west/wp-content/uploads/sites/48/2022/04/GMEC-Cardiac-Disease-in-Pregnancy-FINAL-V2-APRIL-2022.pdf.
  17. Suraya I. Kehamilan dengan penyakit jantung: Penghalang atau tantangan. ARKAVI 2016;1(1). Available from: https://journal.uhamka.ac.id/index.php/arkavi/article/view/278.
  18. Sterguopoulos K. Heart failure in pregnancy: A problem hiding in plain sight. J Am Heart Assoc 2019;8(9):1–3. DOI: 10.1161/JAHA/119.012905.
  19. Ramlakhan KP, Johnson MR, Roos-Hesselink JW. Pregnancy and cardiovascular disease. Nat Rev Cardiol 2020;17(11):718–731. DOI: 10.1038/s41569-020-0390-z.
  20. Farhan HA, Yaseen IF. Heart disease in pregnancy-clinical pattern and prevalence: Initial data from the first cardio-maternal unit in Iraq. BMC Res Notes 2019;12(1):491. DOI: 10.1186/s13104-019- 4523-6.
  21. Van Hagen IM, Roos-Hesselink JW. Pregnancy in congenital heart disease: Risk prediction and counselling. Heart 2020;106(23):1853–1861. DOI: 10.1136/heartjnl-2019-314702.
  22. Pulmonary valve stenosis. [online] www.heart.org. Available from: https://www.heart.org/en/health-topics/congenital-heart-defects/about-congenital-heart-defects/pulmonary-valve-stenosis.
  23. Roos-Hesselink J, Baris L, Johnson M, et al. Pregnancy outcomes in women with cardiovascular disease: Evolving trends over 10 years in the ESC Registry of Pregnancy and Cardiac disease (ROPAC). Eur Heart J 2019;40(47):3848–3855. DOI: 10.1093/EURHEARTJ/EHZ136.
  24. Muninggar L. Maternal mortality risk factor in pregnancy with heart disease at Dr. Soetomo General Hospital, Surabaya, Indonesia. Majalah Obstet Ginekol 2019;27(1). DOI: 10.20473/mog.v1i12019. 17-23.
  25. Rinta F. Gambaran kardiomiopati peripartum di Rumah Sakit Santo Antonius Pontianak tahun 2008–2012. Jurnal Mahasiswa PSPD FK Universitas Tanjungpura 2016;2(1). Available from: http://ejurnalmalahayati.ac.id/index.php/kesehatan.
  26. Azizah N, Soraya DR, Tessy T. Penyakit jantung dalam kehamilan di RSUP Wahidin Sudirohusodo tahun 2016–2018. Abstract PIT POGI XXIV 2019;27(Special Issue 1):67–22.
  27. Mogos MF, Piano MR, McFarlin BL, et al. Heart failure in pregnant women: A concern across the pregnancy continuum. Circ Heart Fail 2018;11(1):e004005. DOI: 10.1161/circheartfailure.117.004005.
  28. Matshela MR. Ischaemic heart disease and pregnancy: The tale of two stories. Cardiovasc J Afr 2018;29(2):e8–e12. DOI: 10.5830/cvja-2017-050.
  29. Vaughan G, Tune K, Peek MJ, et al. Rheumatic heart disease in pregnancy: Strategies and lessons learnt implementing a population-based study in Australia. Int Health 2018;10(6):480–489. DOI: 10.1093/inthealth/ihy048.
  30. Cunningham GF, Leveno KJ, Bloom SL, et al. Disorders of the Cardiovascular System, Chapter 49, Williams Obstetrics. 25th ed. New York: McGraw Hill Education; 2018. pp. 873–875.
  31. Roos-Hesselink JW, Cornette J, Sliwa K, et al. Contraception and cardiovascular disease. Eur Heart J 2015;36(27):1728–1734. DOI: 10.1093/eurheartj/ehv141.
  32. Galiè N, McLaughlin VV, Rubin LJ, et al. An overview of the 6th world symposium on pulmonary hypertension. Eur Respir J 2019;53(1):1802148. DOI: 10.1183/13993003.02148-2018.
  33. Hartopo AB, Anggrahini DW, Nurdiati DS, et al. Severe pulmonary hypertension and reduced right ventricle systolic function associated with maternal mortality in pregnant uncorrected congenital heart diseases. Pulmonary Circulation 2019;9(4). DOI: 10.1177/2045894019884516.
  34. Ramdurg H. Management of heart diseases in pregnancy at a tertiary centre: A case series. Indian Journal of Obstetrics and Gynecology Research 2017;4(4):395–398. DOI: 10.18231/2394-2754.2017.0088.
  35. Naderi N. The time interval between the onset of tricuspid E wave and annular Ea wave (TE-Ea) can predict right atrial pressure in patients with heart failure. Anatol J Cardiol 2014;14(7):585–590. DOI: 10.5152/akd.2014.5025.
  36. Erkamp JS, Cornette J. Contraception and cardiovascular disease. In: Pregnancy and Congenital Heart Disease. Cham: Springer International Publishing; 2017. pp. 23–33.
  37. Kernell K. Cardiac disease in pregnancy and consequences for reproductive outcomes, comorbidity and survival. Acta Obstetricia et Gynecologica Scandinavica 2017;96(10):1235–1241. DOI: 10.1111/aogs.13170.
  38. Sawlani N, Shroff A and Vidovich MI. Aortic dissection and mortality associated with pregnancy in the United States. J Am Coll Cardiol 2015;65:1600–1601. DOI: 10.1016/j.jacc.2014.12.066.
  39. Brener MI, Keramati AR. Type B dissection in a pregnant woman managed with peripartum thoracic endovascular aortic repair. Circulation 2016;133:e369–e373. DOI: 10.1161/CIRCULATIONAHA.115.019735.
  40. Smith K, Gros B. Pregnancy-related acute aortic dissection in Marfan syndrome: A review of the literature. Congenit Heart Dis 2017;12:251–260. DOI: 10.1111/chd.12465.
  41. Henry D, Gonzalez JM, Harris IS, et al. Maternal arrhythmia and perinatal outcomes. J Perinatol 2016;36(10):823–827. DOI: 10.1038/jp.2016.90.
  42. Bauersachs J, Arrigo M, Hilfiker-Kleiner D, et al. Current management of patients with severe acute peripartum cardiomyopathy: Practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 2016;18(9):1096–1105. DOI: 10.1002/ejhf.586.
  43. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Circulation 2018;138(13). DOI: 10.1161/CIR.0000000000000549.
  44. González A, Ravassa S, López B, et al. Myocardial remodeling in hypertension: Toward a new view of hypertensive heart disease. Hypertension 2018;72(3):549–558. DOI: 10.1161/HYPERTENSIONAHA.
  45. Sharma P, Malik R. Fetomaternal outcome in women with heart disease in urban population in a tertiary care hospital. Int J Reprod Contracept Obstet Gynecol 2018;7(9):3684. DOI: 10.18203/2320-1770.ijrcog20183777.
  46. Elkayam U, Goland S, Pieper PG, et al. High-risk cardiac disease in pregnancy. J Am Coll Cardiol 2016;68(4):396–410. DOI: 10.1016/j.jacc.2016.05.048.
  47. De Viti D, Malvasi A, Busardò F, et al. Cardiovascular outcomes in advanced maternal age delivering women. clinical review and medico-legal issues. Medicina 2019;55(10):658. DOI: 10.3390/medicina55100658.
  48. Gaillard R. Maternal obesity during pregnancy and cardiovascular development and disease in the offspring. Eur J Epidemiol 2015;30(11):1141–1152. DOI: 10.1007/s10654-015-0085-7.
  49. Gaudet MM, Carter BD, Hildebrand JS, et al. Associations of parity and age at first pregnancy with overall and cause-specific mortality in the Cancer Prevention Study II. Fertil Steril 2017;107(1):179–188.e6. DOI: 10.1016/j.fertnstert.2016.09.043.
  50. Hauspurg A, Ying W, Hubel CA, et al. Adverse pregnancy outcomes and future maternal cardiovascular disease. Clin Cardiol 2018;41(2):239–246. DOI: 10.1002/CLC.22887.
  51. Heida KY, Velthuis BK, Oudijk MA, et al. Cardiovascular disease risk in women with a history of spontaneous preterm delivery: A systematic review and meta-analysis. Eur J Prev Cardiol 2016;23(3):253–263. DOI: 10.1177/2047487314566758.
  52. Hossinzadeh R, Parizad R, Toufan Tabrizi M, et al. Prevalence of heart diseases in pregnant women referred to the heart diseases clinic for obstetrics. Int J Women S Health Reprod Sci 2017;6(1):80–83. DOI: 10.15296/ijwhr.2018.14.
  53. Kampman MAM, Valente MAE, van Melle JP, et al. Cardiac adaption during pregnancy in women with congenital heart disease and healthy women. Heart 2016;102(16):1302–1308. DOI: 10.1136/heartjnl- 2015-308946.
  54. Bender J, Russell K, Rosenfeld L, editors. Chapter 15, Heart Disease in Pregnancy, Oxford American Handbook of Cardiology. Oxford: Oxford University Press; 2010. pp. 405-10.
  55. Cunningham GF. Williams obstetrics, 24th edition. New York: McGraw Hill Education; 2014.
  56. Fitriany J, Annisa I. Demam reumatik akut. AVERROUS: Jurnal Kedokteran dan Kesehatan Malikussaleh 2019;5(2):11–25. DOI: 10.29103/averrous.v5i2.
  57. Kim D-H, Choe YJ, Jeong J-Y. Understanding and interpretation of case fatality rate of Coronavirus disease 2019. J Korean Med Sci 2020;35(12). DOI: 10.3346/jkms.2020.35.e137.
  58. Hu J, Ye Y, Lu A. Pregnancy outcomes in patients with heart disease in China. American J Cardiol 2020;125(11):1718–1724. DOI: 10.1016/j.amjcard.2020.02.043.
  59. Iftikhar SF, Biswas M. Cardiac disease in pregnancy. StatPearls Publishing; 2022
  60. Shrestha P, Kuikel S, Bajracharya S, et al. Pregnancy with heart disease in South Asia: A systematic review and meta-analysis of prevalence and outcome. Ann Med Surg (Lond) 2022;80:104293. DOI: 10.1016/j.amsu.2022.104293.
  61. Puspa Pitaloka C, Secka A, Ernawati E, et al. Characteristics shifting of heart disease in pregnancy: A report from low middle-income country. J Public Health Res 2021;10(4):2137. DOI: 10.4081/jphr.2021.2137.
  62. Lumsden R, Barasa F, Park LP, et al. High burden of cardiac disease in pregnancy at a national referral hospital in western Kenya. Glob Heart 2020;15(1):10. DOI: 10.5334/gh.404.
  63. Manh TN, Van NB, Thi H. Pregnancy with heart disease: Maternal outcomes and risk factors for fetal growth restriction. Int J Environ Res Public Health 2019;16(12):2075. DOI: 10.3390/ijerph16122075.
  64. Magun E, DeFilippis EM, Noble S, et al. Cardiovascular care for pregnant women with cardiovascular disease. J Am Coll Cardiol 2020;76(18):2102–2113. DOI: 10.1016/j.jacc.2020.08.071.
  65. Meneguin S, Fernandes Pollo C, De Souza JM, et al. High-risk pregnancy in women with heart disease. Enferm Cuid Humaniz 2020;9(2):160–169. DOI: 10.22235/ech.v9i2.2087.
  66. Azize DA, Miriam O, Mohammed M, et al. Prevalence and adverse effects of maternal obesity among women attending antenatal care clinics at a metropolitan hospital in Southern Ghana. Open J Obstet Gynecol 2021;11(11):1629–1638.
  67. Chen C, Xu X, Yan Y. Estimated global overweight and obesity burden in pregnant women based on panel data model. PLoS ONE 2018;13(8):e0202183. DOI: 10.1371/journal.pone.0202183.
  68. Grieger JA, Hutchesson MJ, Cooray SD, et al. A review of maternal overweight and obesity and its impact on cardiometabolic outcomes during pregnancy and postpartum. Ther Adv Reprod Health 2021;15:263349412098654. DOI: 10.1177/2633494120986544.
  69. Wu R, Wang T, Gu R, et al. Hypertensive disorders of pregnancy and risk of cardiovascular disease-related morbidity and mortality: A systematic review and meta-analysis. Cardiology 2020;145(10):633–647. DOI: 10.1159/000508036.
  70. Guimarães T, Magalhães A, Veiga A. Heart disease and pregnancy: State of the art. Rev Port Cardiol (English Edition) 2019;38(5):373–383. DOI: 10.1016/j.repce.2019.06.002.
  71. Mehta LS, Warnes CA, Bradley E, et al. Cardiovascular considerations in caring for pregnant patients: A scientific statement from the American Heart Association. Circulation 2020;141(23):e884–e903. DOI: 10.1161/cir.0000000000000772.
  72. Petrus AHJ, Jongert BL, Kiès P, et al. Evaluation of mode of birth in heart disease in expectant mothers. Eur J Obstet Gynecol Reprod Biol 2020;248:150–155. DOI: 10.1016/j.ejogrb.2020.03.013.
  73. Khan DA, Sharma N, Kapoor M. The spectrum of heart disease in pregnancy and its outcome in patients visiting a tertiary care centre of North East: A prospective study. J Clin Diagn Res 2018;12(7): QC16–QC20. DOI: 10.7860/JCDR/2018/35407.11837.
  74. Owens A, Yang J, Nie L, et al. Neonatal and maternal outcomes in pregnant women with cardiac disease. J Am Heart Assoc 2018;7(21):e009395. DOI: 10.1161/JAHA.118.009395.
  75. Javaid A, Majid A, Aslam S. Maternal and fetal outcome of pregnant patients having preexisting cardiovascular disease. Cureus 2020;12:10–13. DOI: 10.7759/cureus.9563.
  76. Bright RA, Lima FV, Avila C, et al. Maternal heart failure. J Am Heart Assoc 2021;10(14):e021019. DOI: 10.1161/JAHA.121.021019.
  77. Nayak A, Swain AK, Patel PK. Acute respiratory failure during pregnancy. J Med Sci Clin Res 2016;4(2):9351–9358. DOI: 10.1097/00003081-199603000-00013.
  78. Cypher RL. Pulmonary edema in obstetrics: Essential facts for critical care nurses. AACN Adv Cri Care 2018;29(3):327–335. DOI: 10.4037/aacnacc2018958.
  79. Tapaskar N, Tremblay-Gravel M, Khush KK. Contemporary management of cardiogenic shock during pregnancy. J Card Fail 2023;29(2):193–209. DOI: 10.1016/j.cardfail.2022.09.014.
  80. Banayan JM, Rana S, Mueller A, et al. Cardiogenic shock in pregnancy: Analysis from the National Inpatient Sample. Hypertens Preg 2017;36(2):117–123.
  81. Meng M-L, Arendt KW, Banayan JM, et al. Anesthetic care of the pregnant patient with cardiovascular disease: A scientific statement from the American Heart Association. Circulation 2023;147(11):e657–e673. DOI: 10.1161/cir.0000000000001121.
  82. Abu-Awwad S-A, Craina M, Gluhovschi A, et al. Comparative analysis of neonatal effects in pregnant women with cardiovascular risk versus low-risk pregnant women. J Clin Med 2023;12(12):4082. DOI: 10.3390/jcm12124082.
  83. Kinra S, Gregson J, Prabhakaran P, et al. Effect of supplemental nutrition in pregnancy on offspring's risk of cardiovascular disease in young adulthood: Long-term follow-up of a cluster trial from India. PLOS Med 2020;17(7):e1003183. DOI: 10.1371/journal.pmed.1003183.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.